HK1029922A1 - Angiostatic agents and compositions for treating glc1a glaucoma - Google Patents
Angiostatic agents and compositions for treating glc1a glaucomaInfo
- Publication number
- HK1029922A1 HK1029922A1 HK01100647A HK01100647A HK1029922A1 HK 1029922 A1 HK1029922 A1 HK 1029922A1 HK 01100647 A HK01100647 A HK 01100647A HK 01100647 A HK01100647 A HK 01100647A HK 1029922 A1 HK1029922 A1 HK 1029922A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- angiostatic agents
- treating
- glc1a glaucoma
- glaucoma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0027—Azides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/994,114 US5990099A (en) | 1988-10-31 | 1997-12-19 | Angiostatic agents and methods and compositions for controlling ocular hypertension |
PCT/US1998/025913 WO1999032127A1 (en) | 1997-12-19 | 1998-12-07 | Angiostatic agents and compositions for controlling ocular hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1029922A1 true HK1029922A1 (en) | 2001-04-20 |
Family
ID=25540297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01100647A HK1029922A1 (en) | 1997-12-19 | 2001-01-29 | Angiostatic agents and compositions for treating glc1a glaucoma |
Country Status (13)
Country | Link |
---|---|
US (1) | US5990099A (de) |
EP (1) | EP1039912B1 (de) |
JP (1) | JP2001526233A (de) |
AT (1) | ATE221781T1 (de) |
AU (1) | AU734436B2 (de) |
BR (1) | BR9813684A (de) |
CA (1) | CA2315829C (de) |
DE (1) | DE69807115T2 (de) |
DK (1) | DK1039912T3 (de) |
ES (1) | ES2177112T3 (de) |
HK (1) | HK1029922A1 (de) |
PT (1) | PT1039912E (de) |
WO (1) | WO1999032127A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1935501A (en) * | 1999-12-09 | 2001-06-18 | Alcon Universal Limited | Id protein inhibitors for treating ocular diseases |
US9820883B2 (en) | 2000-05-19 | 2017-11-21 | Michael S. Berlin | Method for treating glaucoma |
US9603741B2 (en) | 2000-05-19 | 2017-03-28 | Michael S. Berlin | Delivery system and method of use for the eye |
US8679089B2 (en) | 2001-05-21 | 2014-03-25 | Michael S. Berlin | Glaucoma surgery methods and systems |
WO2003029268A1 (en) * | 2001-10-03 | 2003-04-10 | Merck & Co., Inc. | Androstane 17-beta-carboxamides as androgen receptor modulators |
GB0316290D0 (en) | 2003-07-11 | 2003-08-13 | Glaxo Group Ltd | Novel compounds |
US7579335B2 (en) | 2005-01-10 | 2009-08-25 | Glaxo Group Limited | Androstane 17α-carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
WO2007009087A2 (en) * | 2005-07-12 | 2007-01-18 | Dmi Biosciences, Inc. | Methods and products for treatment of diseases |
US20170360609A9 (en) | 2007-09-24 | 2017-12-21 | Ivantis, Inc. | Methods and devices for increasing aqueous humor outflow |
JP2011513002A (ja) | 2008-03-05 | 2011-04-28 | イバンティス インコーポレイテッド | 緑内障を治療する方法及び器具 |
DK2278978T3 (en) | 2008-05-28 | 2015-09-21 | Reveragen Biopharma Inc | NON-HORMONAL STEROID MODULATORS OF NF-KB FOR TREATMENT OF DISEASE |
PT2554174E (pt) | 2009-06-22 | 2015-12-15 | Ampio Pharmaceuticals Inc | Método para o tratamento de doenças |
BRPI1010086A2 (pt) * | 2009-06-22 | 2018-02-06 | Dmi Acquisition Corp | método e produtos para tratamento de doenças |
WO2011006078A1 (en) | 2009-07-09 | 2011-01-13 | Ivantis, Inc. | Single operator device for delivering an ocular implant |
AU2010271218B2 (en) | 2009-07-09 | 2017-02-02 | Alcon Inc. | Ocular implants and methods for delivering ocular implants into the eye |
US9198921B2 (en) | 2010-04-05 | 2015-12-01 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
US20120283557A1 (en) | 2011-05-05 | 2012-11-08 | Berlin Michael S | Methods and Apparatuses for the Treatment of Glaucoma using visible and infrared ultrashort laser pulses |
US8657776B2 (en) | 2011-06-14 | 2014-02-25 | Ivantis, Inc. | Ocular implants for delivery into the eye |
US8663150B2 (en) | 2011-12-19 | 2014-03-04 | Ivantis, Inc. | Delivering ocular implants into the eye |
US9358156B2 (en) | 2012-04-18 | 2016-06-07 | Invantis, Inc. | Ocular implants for delivery into an anterior chamber of the eye |
US10617558B2 (en) | 2012-11-28 | 2020-04-14 | Ivantis, Inc. | Apparatus for delivering ocular implants into an anterior chamber of the eye |
SG10201705044YA (en) | 2012-12-19 | 2017-07-28 | Ampio Pharmaceuticals Inc | Method for treatment of diseases |
US10709547B2 (en) | 2014-07-14 | 2020-07-14 | Ivantis, Inc. | Ocular implant delivery system and method |
EP3006453A1 (de) | 2014-10-08 | 2016-04-13 | Cosmo Technologies Ltd. | 17alpha-Monoester und 17alpha,21-Diester von Cortodoxon zur Verwendung bei der Behandlung von Tumoren |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
CN108135470B (zh) | 2015-08-14 | 2021-03-09 | 伊万提斯公司 | 具有压力传感器和输送系统的眼部植入物 |
US11938058B2 (en) | 2015-12-15 | 2024-03-26 | Alcon Inc. | Ocular implant and delivery system |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
EP4274529A1 (de) | 2021-01-11 | 2023-11-15 | Alcon Inc. | Systeme und verfahren zur viskoelastischen freisetzung |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4642355A (en) * | 1984-02-24 | 1987-02-10 | Otsuka Pharmaceutical Factory, Inc. | Proline derivatives |
US4863912A (en) * | 1986-05-19 | 1989-09-05 | New York Medical College | Use of tetrahydrocortisol in glaucoma therapy |
US4876250A (en) * | 1988-10-31 | 1989-10-24 | Alcon Laboratories, Inc. | Methods for controlling ocular hypertension with angiostatic steroids |
US5371078A (en) * | 1988-10-31 | 1994-12-06 | Alcon Laboratories, Inc. | Angiostatic steroids and methods and compositions for controlling ocular hypertension |
ATE190623T1 (de) * | 1990-06-11 | 2000-04-15 | Alcon Lab Inc | Verwendung von steroiden zur inhibierung von angiogenesis |
EP0614463B1 (de) * | 1991-11-22 | 2003-02-12 | Alcon Laboratories, Inc. | Angiostatische steroide |
US5646136A (en) * | 1994-01-04 | 1997-07-08 | Duke University | Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
US5606043A (en) * | 1994-11-03 | 1997-02-25 | The Regents Of The University Of California | Methods for the diagnosis of glaucoma |
-
1997
- 1997-12-19 US US08/994,114 patent/US5990099A/en not_active Expired - Fee Related
-
1998
- 1998-12-07 ES ES98961956T patent/ES2177112T3/es not_active Expired - Lifetime
- 1998-12-07 CA CA002315829A patent/CA2315829C/en not_active Expired - Fee Related
- 1998-12-07 DE DE69807115T patent/DE69807115T2/de not_active Expired - Lifetime
- 1998-12-07 JP JP2000525118A patent/JP2001526233A/ja active Pending
- 1998-12-07 PT PT98961956T patent/PT1039912E/pt unknown
- 1998-12-07 DK DK98961956T patent/DK1039912T3/da active
- 1998-12-07 WO PCT/US1998/025913 patent/WO1999032127A1/en active IP Right Grant
- 1998-12-07 EP EP98961956A patent/EP1039912B1/de not_active Expired - Lifetime
- 1998-12-07 AT AT98961956T patent/ATE221781T1/de active
- 1998-12-07 BR BR9813684-4A patent/BR9813684A/pt not_active Application Discontinuation
- 1998-12-07 AU AU17142/99A patent/AU734436B2/en not_active Ceased
-
2001
- 2001-01-29 HK HK01100647A patent/HK1029922A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5990099A (en) | 1999-11-23 |
ES2177112T3 (es) | 2002-12-01 |
ATE221781T1 (de) | 2002-08-15 |
EP1039912B1 (de) | 2002-08-07 |
DK1039912T3 (da) | 2002-10-28 |
EP1039912A1 (de) | 2000-10-04 |
AU734436B2 (en) | 2001-06-14 |
JP2001526233A (ja) | 2001-12-18 |
DE69807115D1 (de) | 2002-09-12 |
AU1714299A (en) | 1999-07-12 |
WO1999032127A1 (en) | 1999-07-01 |
DE69807115T2 (de) | 2002-12-12 |
PT1039912E (pt) | 2002-12-31 |
BR9813684A (pt) | 2000-10-10 |
CA2315829A1 (en) | 1999-07-01 |
CA2315829C (en) | 2009-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1029922A1 (en) | Angiostatic agents and compositions for treating glc1a glaucoma | |
DE69717312D1 (de) | Intestinale absorption von nikotin für die behandlung von nikotinabhängigen zustanden | |
CY2473B1 (en) | New phenanthridines. | |
CY2431B1 (en) | Novel phenanthridines substituted in the 6 position. | |
MY114014A (en) | Imidazole compounds, compositions and use | |
MX9707570A (es) | Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria. | |
MY106484A (en) | Combination therapy for phophylaxis and/or treatment of benign prostatic hyperplasia. | |
IL164568A0 (en) | Compounds and methods for the inhibition of the expression of vcam-1 | |
PL349028A1 (en) | Cancer treatment composition and method using natural plant essential oils | |
IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
ATE247709T1 (de) | 3'utr des menschliches prohibitin-gens | |
AU8020698A (en) | Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain | |
PL314799A1 (en) | Application of dimeticone in treating constipations | |
TWI262791B (en) | 6-methoxy-2-naphthylacetic acid prodrugs | |
HK1039568A1 (en) | Use of ap-1 activators to treat glaucoma and ocular hypertension. | |
BG105549A (en) | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system | |
AP9600780A0 (en) | Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent. | |
AU7799898A (en) | Compositions and methods for treating glaucoma | |
AU3643295A (en) | Compositions of melatonin and analgetic agents and methods of use thereof | |
MX9709450A (es) | Piridiniminil-1,2-benzoisoxazoles y -benzoisotiazoles como agentes antipsicoticos. | |
MX9709912A (es) | Compuestos de imidazol, procedimiento para prepararlos y uso de los mismos. | |
UA31995A (uk) | Засіб для профілактики і лікування гіпогалактії | |
MX9709908A (es) | Compuestos cetoheterociclicos, uso de los mismos y composiciones que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20111207 |